United Kingdom
MHRA moved lidocaine teething gels behind the pharmacy counter
December 2018, effective 2019
Following advice from the Commission on Human Medicines, all oral lidocaine products licensed for infant teething were reclassified from general sale to pharmacy medicines. The review found a lack of evidence of benefit from using these products ahead of non-medicinal options, and repositioned them as a second line choice, for use only when simple measures have not worked. Pack sizes were limited to 10g and the warnings on pack were updated.
The MHRA also stated that its evidence of any risk associated with these products is very small given how widely they are used.
MHRA Drug Safety Update, December 2018